Nick Conti, PhD, is responsible for the licensing, strategic alliance and business development activities for Quest Diagnostics, a $7 billion diagnostic testing corporation. He has been in business development, management and R&D positions with Becton Dickinson and Union Carbide. He had held visiting and adjunct faculty positions at Rutgers (Chemistry) and Seton Hall (Finance). He serves on several boards of start-ups and is an advisor to funds. He holds a Ph.D. from the University of Florida, a B.S. in Chemistry from Notre Dame, and an MBA from The Wharton School.